Showing results (221-230 of 315) with videos related to
Sort By:
Pageof 32
Cancer Chemotherapy and Pharmacology|January 1, 1981
Chemotherapy of ovarian cancer directed by the human tumor stem cell assayD S Alberts, H S Chen, S E Salmon, et al.Gynecologic Oncology|June 1, 1990
A phase II trial of cisplatin and 5-fluorouracil with allopurinol for recurrent or metastatic carcinoma of the uterine cervix: a Southwest Oncology Group trialG R Weiss, S Green, E V Hannigan, et al.American Journal of Clinical Oncology|February 1, 1990
Pharmacokinetics of very high-dose oral melphalan in cancer patientsL Boros, Y M Peng, D S Alberts, et al.Investigational New Drugs|January 1, 1986
Phase II trial of esorubicin (4' deoxydoxorubicin) in cancers of the breast, colon, kidney, lung and melanomaT A Braich, S E Salmon, A Robertone, et al.Cancer Chemotherapy and Pharmacology|January 1, 1981
Quantitative association between the in vitro human tumor stem cell assay and clinical response to cancer chemotherapyT E Moon, S E Salmon, C S White, et al.Investigational New Drugs|January 1, 1984
m-AMSA and adenocarcinoma of the endometrium. A Southwest Oncology Group studyR D Hilgers, S S Legha, G A Johnston, et al.Cancer Chemotherapy and Pharmacology|January 1, 1997
In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancersD S Alberts, P T Fanta, K L Running, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1987
Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group StudyD S Alberts, R Kronmal, L H Baker, et al.Journal of the National Cancer Institute|December 4, 1991
Lack of ranitidine effects on cyclophosphamide bone marrow toxicity or metabolism: a placebo-controlled clinical trialD S Alberts, N Mason-Liddil, P M Plezia, et al.Journal of the National Cancer Institute|August 3, 1994
Dose de-escalation chemoprevention trial of alpha-difluoromethylornithine in patients with colon polypsF L Meyskens, S S Emerson, D Pelot, et al.Pageof 32